This originally appeared at https://link.springer.com/article/10.1007/s11292-018-9345-3
Bradley J. Bartos ORCID: orcid.org/0000-0001-5289-36541, Carol Newark1 & Richard McCleary1
Abstract
Objectives
This paper reports a quasi-experimental evaluation of California’s 1996 medical marijuana law (MML), known as Proposition 215, on statewide motor vehicle fatalities between 1996 and 2015.
Methods
To infer the causal impact of California’s MML enactment on statewide motor vehicle fatalities, we construct a synthetic control group for California (i.e., California had it NOT enacted MMLs) as a weighted sum of annual traffic fatality time series from a donor pool of untreated (no MML) states. The post-MML difference between California and its constructed counterfactual reflects the net effect of MMLs on statewide traffic fatalities. The synthetic control group design avoids the problematic homogeneity assumptions intrinsic to panel regression models, which have been employed in prominent studies of this topic.
Results
California’s 1996 MML appears to have produced a large, sustained decrease in statewide motor vehicle fatalities amounting to an annual reduction between 588 and 900 vehicle fatalities. This finding is consistent across a wide range of model specifications and donor pool restrictions. In-sample placebo test results suggest that the estimated intervention effect is unlikely to be a spurious artifact and the “leave-one-out” sensitivity analysis demonstrates that the effect is not being driven by an individual or ensemble of influential donor pool states.
Conclusions
Our focus on California as a case study limits our ability to generalize our estimate of the MML intervention on motor vehicle fatalities in California to other MML states; however, state-level MML interventions have major differences in their policy dimensions that seem unlikely to “average out” through aggregation.
